Tag: INSM

Blue Horseshoe Stocks: IDXG Recap & More

Interpace Diagnostics Group, Inc. IDXG

We last talked about IDXG on the 16th of last month. (Please excuse us for being currently unable to provide the link to that report like we normally would, as our primary servers are located in Houston, and our service provider is still recovering in the wake of Hurricane Harvey.) Subsequent to that mention, we observed a low of .72 in IDXG, and the run we’ve seen has been pretty impressive.

Yesterday the stock hit 1.73, which represents a 140% increase, and the stock closed with strength just below its high of day, so we’ll be interested to see if there will be further gains in store. The key for IDXG will be to maintain above the NASDAQ minimum bid requirement of a dollar per share on any pullbacks.

Insmed, Inc. INSM – Options Update

We highlighted our interest in a set of options for INSM in yesterday’s report to try to take advantage of the flux in activity caused by the company’s positive Phase III results on its rare lung disease treatment study.

We saw the beginnings of what could be a good idea that we’ll want to continue tracking in the INSM 09/15 $27-30 Calls. The $27’s we’re the only ones that were pushed into the money, and they did manage an intraday run from a low of .95 to 1.60 for a 68% swing on the day. We’ll continue to keep an eye on these contracts if INSM can manage to record higher lows over the next few sessions.

Extended Watchlist:
VSTM, VYGR, BCRX, PTN, CBIO, IMUN, PLX

Blue Horseshoe Stocks: New Options Idea & More

Acacia Research Corp. ACTG

Pretty much the entirety of 2017 has been some tough sledding for ACTG, which was in an overall downtrend since last winter when it was trading at more than twice its current value.

That all seemed to change around midway through last month, as the stock has managed to establish a good rebound effort for several sessions. In the premarket the stock has broken previous resistance which coincided with the 50DMA (3.63) and could make a move to fill that gao we’ve pointed out on the chart below.

We’ll put the stock on watch in the days and weeks ahead as we kick off this holiday-shortened trading week.

Insmed, Inc. INSM

After posting key data reflecting positive top-line results in its Phase III lung disease treatment study, INSM has exploded into the blue sky this morning. The stock has rapidly gained more than twice its value in premarket trading, and whenever we come across a situation like this, we begin to look for the options contracts that could give us the best opportunity for rapid gains.

We think that the INSM 09/15 $27-30 Calls could stand to see some nice activity if the stock continues the blue-sky breakout we’ve witnessed so far.

Extended Watchlist:
ONCI, VDRM, MYDX, BSTG, PTN, BSRX, BLPH

IWEB, CLNO & Extended Watchlist

IceWEB, Inc. IWEB
–
IWEB is looking strong this midweek, after having achieved higher lows and higher highs for the past three sessions. After the initial run we saw out of IWEB last week from .024-.0355, and several subsequent bounces, the stock settled back and found support around our original alert price. Since then it has been steadily building back up, currently holding above the 50DMA of .0259. Looking ahead, our key resistance point is last week’s swing high of .0355.

Although IWEB has worked out well for us in the short term this week, we are still attracted to the stock for its long-term potential as well. We’re anxious to follow along as the company continues to pursue its well-laid plans for expanding into a full-range cloud services provider.

Cleantech Transit, Inc. CLNO

Many of you will recall CLNO as a stock that brought forth the chance at nearly 5000% in gains this spring, as it exploded from our original alert price of .0055, to a high of .365. At that point we saw a tapering of the chart, and after observing a bottom, yesterday we got CLNO back onto our watchlist just in the nick of time.

After opening at .13 and touching a low of .12, the stock rose as high as .225, an intraday gain of up to 88%

Extended Watchlist:
SPEX, INSM, ABIO, RNN